113 related articles for article (PubMed ID: 15063483)
1. Biology: risk factor modification by OCs and HRT lipids and lipoproteins.
Godsland IF
Maturitas; 2004 Apr; 47(4):299-303. PubMed ID: 15063483
[TBL] [Abstract][Full Text] [Related]
2. [Lipids, lipoproteins, arterial accidents and oral contraceptives].
Bakir R; Hilliquin P
Contracept Fertil Sex (Paris); 1986 Jan; 14(1):81-7. PubMed ID: 12341243
[TBL] [Abstract][Full Text] [Related]
3. Effects of oral contraceptives on lipid metabolism.
Krauss RM
J Reprod Med; 1986 Jun; 31(6 Suppl):549-50. PubMed ID: 3723487
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.
Sitruk-Ware RL; Menard J; Rad M; Burggraaf J; de Kam ML; Tokay BA; Sivin I; Kluft C
Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148
[TBL] [Abstract][Full Text] [Related]
5. Oral contraceptives and lipoprotein metabolism.
Tikkanen MJ; Nikkilä EA
J Reprod Med; 1986 Sep; 31(9 Suppl):898-905. PubMed ID: 3772909
[TBL] [Abstract][Full Text] [Related]
6. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
[TBL] [Abstract][Full Text] [Related]
7. The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters.
Winkler UH; Sudik R
Contraception; 2009 Jan; 79(1):15-23. PubMed ID: 19041436
[TBL] [Abstract][Full Text] [Related]
8. Lipid profile in women over 35 years old using triphasic combined oral contraceptives.
Aldrighi JM; Petta CA; Bahamondes L; Caetano ME; Martinez TR; De Lima GR
Contraception; 2004 May; 69(5):395-9. PubMed ID: 15105062
[TBL] [Abstract][Full Text] [Related]
9. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.
Vrablik M; Fait T; Kovar J; Poledne R; Ceska R
Metabolism; 2008 Aug; 57(8):1088-92. PubMed ID: 18640386
[TBL] [Abstract][Full Text] [Related]
10. The case for a nonplasma lipoprotein etiology of reduced vascular risk in estrogen replacement therapy.
de Lignieres B
Curr Opin Obstet Gynecol; 1993 Jun; 5(3):389-95. PubMed ID: 8329655
[TBL] [Abstract][Full Text] [Related]
11. Cardioprotection by estrogens: mechanisms of action--the lipids.
Samsioe G
Int J Fertil Menopausal Stud; 1994; 39 Suppl 1():43-9. PubMed ID: 8199640
[TBL] [Abstract][Full Text] [Related]
12. Lipid profile during hormone replacement therapy: effect of different progestins?
Campagnoli C; Belforte P; Di Sario MM; Lesca L
Zentralbl Gynakol; 1997; 119 Suppl 2():1-6. PubMed ID: 9361391
[TBL] [Abstract][Full Text] [Related]
13. [Estrogens, progestins and blood lipids].
Tikkanen MJ
Duodecim; 1984; 100(22):1500-3. PubMed ID: 6518995
[TBL] [Abstract][Full Text] [Related]
14. Lipid and lipoprotein profile in physiological pregnancy.
Lippi G; Albiero A; Montagnana M; Salvagno GL; Scevarolli S; Franchi M; Guidi GC
Clin Lab; 2007; 53(3-4):173-7. PubMed ID: 17447654
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of lipid profile in adolescents during long-term use of combined oral hormonal contraceptives.
Guazzelli CA; Lindsey PC; de Araújo FF; Barbieri M; Petta CA; Aldrighi JM
Contraception; 2005 Feb; 71(2):118-21. PubMed ID: 15707561
[TBL] [Abstract][Full Text] [Related]
16. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.
Chapman MJ; Assmann G; Fruchart JC; Shepherd J; Sirtori C;
Curr Med Res Opin; 2004 Aug; 20(8):1253-68. PubMed ID: 15324528
[TBL] [Abstract][Full Text] [Related]
17. Effects of continuous combined conjugated estrogen/medroxyprogesterone acetate and 17beta-estadiol/norethisterone acetate on lipids and lipoproteins.
Odmark IS; Bäckström T; Haeger M; Jonsson B; Bixo M
Maturitas; 2004 Jun; 48(2):137-46. PubMed ID: 15172088
[TBL] [Abstract][Full Text] [Related]
18. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
Chang TC; Lien YR; Chen M; Cheng SP; Chen RJ; Chow SN
Acta Obstet Gynecol Scand; 2004 Jul; 83(7):661-6. PubMed ID: 15225192
[TBL] [Abstract][Full Text] [Related]
19. Changes in lipid metabolism in postmenopausal Japanese women using hormone therapy evaluated by capillary isotachophoresis: a pilot study.
Inoue Y; Zhang B; Sadamori R; Shirota K; Saku K; Kawarabayashi T
Menopause; 2008; 15(1):157-63. PubMed ID: 17603392
[TBL] [Abstract][Full Text] [Related]
20. The effects of oral contraceptives on plasma lipids and lipoproteins.
Krauss RM
Int J Fertil; 1988; 33 Suppl():35-42. PubMed ID: 2908039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
